Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-28
1997-10-28
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548253, 548537, 514381, A61K 3140, C07D20706
Patent
active
056818440
ABSTRACT:
This invention relates to compounds which inhibit thrombin or factor Xa. The compounds contain an aldehyde functionality and a methionine sulfone or S-substituted cysteine sulfone residue. The compounds and their pharmaceutical compositions are useful for preventing thrombosis in mammals which are suspected of having a condition characterized by abnormal thrombosis.
REFERENCES:
patent: 5153176 (1992-10-01), Abe et al.
patent: 5254546 (1993-10-01), Ardecky et al.
Bajusz et al. Int. J. Peptide Protein Res. 12 (1978) 217-221. (8).
Carini et al., "Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N-(Biphenylylmethyl)imidazoles as Potent, Orally Active Antihypertensives," J. Med. Chem. 34:2525-2547 (1991).
Abelman Matthew M.
Ardecky Robert J.
Nutt Ruth F.
Corvas International Inc.
Richter Johann
Stockton Laura L.
LandOfFree
Methionine sulfone and s-substituted cysteine sulfone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methionine sulfone and s-substituted cysteine sulfone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methionine sulfone and s-substituted cysteine sulfone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026305